Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,739 | 105,138 | 95,141 | 80,728 | 103,285 |
| Marketable Securities | 106,727 | 103,353 | 163,005 | 220,114 | 253,061 |
| Receivables | 38,525 | 41,850 | 33,654 | 37,502 | 34,811 |
| Inventories | 42,629 | 41,905 | 42,749 | 41,442 | 34,849 |
| TOTAL | $272,288 | $314,196 | $350,995 | $392,895 | $438,448 |
| Non-Current Assets | |||||
| PPE Net | 22,704 | 22,737 | 21,741 | 21,886 | 21,908 |
| Other Non-Current Assets | 15,940 | 16,623 | 17,287 | 17,940 | 18,585 |
| TOTAL | $38,644 | $39,360 | $39,028 | $39,826 | $40,493 |
| Total Assets | $310,932 | $353,556 | $390,023 | $432,721 | $478,941 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,689 | 525 | 12,067 | 18,458 | 11,562 |
| Accrued Expenses | 63,848 | 63,559 | 53,953 | 41,366 | 44,091 |
| TOTAL | $100,917 | $102,503 | $97,578 | $92,651 | $96,765 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,790 | 14,561 | 15,298 | 16,012 | 16,708 |
| TOTAL | $13,790 | $14,561 | $15,298 | $16,012 | $16,708 |
| Total Liabilities | $114,707 | $117,064 | $112,876 | $108,663 | $113,473 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,829 | 91,397 | 90,855 | 90,855 | 90,642 |
| Common Shares | 914 | 913 | 909 | 908 | 906 |
| Retained earnings | -1,445,362 | -1,392,748 | -1,330,467 | -1,272,239 | -1,217,049 |
| Other shareholders' equity | 121 | 257 | 540 | 953 | 708 |
| TOTAL | $196,225 | $236,492 | $277,147 | $324,058 | $365,468 |
| Total Liabilities And Equity | $310,932 | $353,556 | $390,023 | $432,721 | $478,941 |